Evaluation of prognostic integrin α2β1 PET tracer and concurrent targeting delivery using focused ultrasound for brain glioma detection

Molecular Pharmaceutics

Volumn 11, Issue 11, 2014, Pages 3904-3914

  Chung, Yi Hsiu ^a   Hsu, Po Hung ^a,b   Huang, Chiun Wei ^a   Hsieh, Wen Chuan ^a   Huang, Feng Ting ^c   Chang, Wen Chi ^a   Chiu, Han ^a   Hsu, Shih Ting ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Focus ultrasound; Glioblastoma; Integrin 2 1; PET imaging

Indexed keywords

GALLIUM 68; TRACER; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 2 GA 68; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MICROBUBBLE; MOUSE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; WESTERN BLOTTING; ANIMAL; BINDING COMPETITION; BRAIN; BRAIN TUMOR; CANCER TRANSPLANTATION; CHEMISTRY; DIAGNOSTIC USE; DISEASE COURSE; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; GLIOMA; HEK293 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; PATHOLOGY; PHENOTYPE; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; BINDING, COMPETITIVE; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; GLIOMA; HEK293 CELLS; HUMANS; INTEGRIN ALPHA2BETA1; MALE; MICE; NEOPLASM TRANSPLANTATION; PEPTIDES; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84938491670     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500296n     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts & Figures 2014. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/ index (accessed March 30, 2014).
2. SEER Cancer Statistics Factsheets: All Cancer Sites. http://seer.cancer.gov/statfacts/html/all.html (accessed March 30, 2014).
3. SEER Cancer Statistics Factsheets: Brain and Other Nervous System Cancer. http://seer.cancer.gov/statfacts/html/brain.html (30 March, 2014).
4. Howlader, N.; Noone, A. M.; Krapcho, M.; Garshell, J.; Neyman, N.; Altekruse, S. F.; Kosary, C. L.; Yu, M.; Ruhl, J.; Tatalovich, Z.; Cho, H.; Mariotto, A.; Lewis, D. R.; Chen, H. S.; Feuer, E. J.; Cronin, K. A., Eds. SEER Cancer Statistics Review, 1975-2010; National Cancer Institute: Bethesda, MD, 2013; http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission (accessed March 30, 2014).
5. Wang, X.; Hagemeyer, C. E.; Hohmann, J. D.; Leitner, E.; Armstrong, P. C.; Jia, F.; Olschewski, M.; Needles, A.; Peter, K.; Ahrens, I. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 2012, 125 (25), 3117-26.
6. Sottnik, J. L.; Daignault-Newton, S.; Zhang, X.; Morrissey, C.; Hussain, M. H.; Keller, E. T.; Hall, C. L. Integrin alpha2beta 1 (alpha2beta1) promotes prostate cancer skeletal metastasis. Clin. Exp. Metastasis 2013, 30 (5), 569-78.
7. Li, X.; Ishihara, S.; Yasuda, M.; Nishioka, T.; Mizutani, T.; Ishikawa, M.; Kawabata, K.; Shirato, H.; Haga, H. Lung cancer cells that survive ionizing radiation show increased integrin alpha2beta1-and EGFR-dependent invasiveness. PLoS One 2013, 8 (8), e70905.
8. Shield, K.; Riley, C.; Quinn, M. A.; Rice, G. E.; Ackland, M. L.; Ahmed, N. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J. Carcinog. 2007, 6, 11.
9. Takenaka, K.; Shibuya, M.; Takeda, Y.; Hibino, S.; Gemma, A.; Ono, Y.; Kudoh, S. Altered expression and function of beta1 integrins in a highly metastatic human lung adenocarcinoma cell line. Int. J. Oncol. 2000, 17 (6), 1187-94.
10. Matsuoka, T.; Yashiro, M.; Nishimura, S.; Inoue, T.; Fujihara, T.; Sawada, T.; Kato, Y.; Seki, S.; Hirakawa-Ys Chung, K. Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma. Int. J. Mol. Med. 2000, 5 (1), 21-5.
11. Huang, C. W.; Li, Z.; Conti, P. S. In vivo near-infrared fluorescence imaging of integrin alpha2beta1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe. J. Nucl. Med. 2011, 52 (12), 1979-86.
12. Huang, C. W.; Li, Z.; Cai, H.; Shahinian, T.; Conti, P. S. Novel alpha(2)beta(1) integrin-targeted peptide probes for prostate cancer imaging. Mol. Imaging 2011, 10 (4), 284-94.
13. Huang, C. W.; Li, Z.; Cai, H.; Chen, K.; Shahinian, T.; Conti, P. S. Design, synthesis and validation of integrin alpha2beta1-targeted probe for microPET imaging of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (7), 1313-22.
14. Wu, C. Y.; Chan, P. C.; Chou, L. S.; Chang, C. W.; Yang, F. Y.; Liu, R. S.; Chiou, S. H.; Chen, Y. W.; Yen, S. H.; Wang, H. E. Pulsed-focused ultrasound enhances boron drug accumulation in a human head and neck cancer xenograft-bearing mouse model. Mol. Imaging Biol. 2014, 16 (1), 95-101.
15. Liu, H. L.; Hua, M. Y.; Chen, P. Y.; Chu, P. C.; Pan, C. H.; Yang, H. W.; Huang, C. Y.; Wang, J. J.; Yen, T. C.; Wei, K. C. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 2010, 255 (2), 415-25.
16. Wang, F.; Cheng, Y.; Mei, J.; Song, Y.; Yang, Y. Q.; Liu, Y.; Wang, Z. Focused ultrasound microbubble destruction-mediated changes in blood-brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging. J. Ultrasound Med. 2009, 28 (11), 1501-9.
17. Juffermans, L. J.; van Dijk, A.; Jongenelen, C. A.; Drukarch, B.; Reijerkerk, A.; de Vries, H. E.; Kamp, O.; Musters, R. J. Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells. Ultrasound Med. Biol. 2009, 35 (11), 1917-27.
18. Zarnitsyn, V.; Rostad, C. A.; Prausnitz, M. R. Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation. Biophys. J. 2008, 95 (9), 4124-38.
19. Skyba, D. M.; Price, R. J.; Linka, A. Z.; Skalak, T. C.; Kaul, S. Direct in vivo visualization of intravascular destruction of micro-bubbles by ultrasound and its local effects on tissue. Circulation 1998, 98 (4), 290-3.
20. Hu, G.; Liu, C.; Liao, Y.; Yang, L.; Huang, R.; Wu, J.; Xie, J.; Bundhoo, K.; Liu, Y.; Bin, J. Ultrasound molecular imaging of arterial thrombi with novel microbubbles modified by cyclic RGD in vitro and in vivo. Thromb. Haemostasis 2012, 107 (1), 172-83.
21. Anderson, C. R.; Hu, X.; Zhang, H.; Tlaxca, J.; Decleves, A. E.; Houghtaling, R.; Sharma, K.; Lawrence, M.; Ferrara, K. W.; Rychak, J. J. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Invest. Radiol. 2011, 46 (4), 215-24.
22. Willmann, J. K.; Cheng, Z.; Davis, C.; Lutz, A. M.; Schipper, M. L.; Nielsen, C. H.; Gambhir, S. S. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology 2008, 249 (1), 212-9.
23. Treat, L. H.; McDannold, N.; Zhang, Y.; Vykhodtseva, N.; Hynynen, K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med. Biol. 2012, 38 (10), 1716-25.
24. Wei, K. C.; Chu, P. C.; Wang, H. Y.; Huang, C. Y.; Chen, P. Y.; Tsai, H. C.; Lu, Y. J.; Lee, P. Y.; Tseng, I. C.; Feng, L. Y.; Hsu, P. W.; Yen, T. C.; Liu, H. L. Focused ultrasound-induced blood-brain barrier opening to enhance Temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS One 2013, 8 (3), e58995.
25. Kovacs, Z.; Werner, B.; Rassi, A.; Sass, J. O.; Martin-Fiori, E.; Bernasconi, M. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J. Controlled Release 2014, 187, 74-82.
26. Greis, C. Technology overview: SonoVue (Bracco, Milan). Eur. Radiol. 2004, 14 (Suppl 8), 6.
27. Banerjee, T.; Mitra, S.; Kumar Singh, A.; Kumar Sharma, R.; Maitra, A. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm. 2002, 243 (1-2), 93-105.
28. Tartis, M. S.; Kruse, D. E.; Zheng, H.; Zhang, H.; Kheirolomoom, A.; Marik, J.; Ferrara, K. W. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J. Controlled Release 2008, 131 (3), 160-6.
29. Nag, O. K.; Yadav, V. R.; Hedrick, A.; Awasthi, V. Postmodification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexade-canoic acid for enhanced circulation persistence in vivo. Int. J. Pharm. 2013, 446 (1-2), 119-29.
30. Yang, F. Y.; Chang, W. Y.; Li, J. J.; Wang, H. E.; Chen, J. C.; Chang, C. W. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy. J. Nucl. Med. 2014, 55, 616-21.
31. Qin, S.; Caskey, C. F.; Ferrara, K. W. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys. Med. Biol. 2009, 54 (6), R27-57.
32. Senft, C.; Bink, A.; Franz, K.; Vatter, H.; Gasser, T.; Scifert, V. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011, 12 (11), 997-1003.
33. Kubben, P. L.; ter Meulen, K. J.; Schijns, O. E.; ter Laak-Poort, M. P.; van Overbeeke, J. J.; van Santbrink, H. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol. 2011, 12 (11), 1062-70.
34. Fujii, M.; Wakabayashi, T. Image-guided neurosurgery using intraoperative MRI. Brain Nerve 2009, 61 (7), 823-34.
35. Zhu, M.; Bashir, A.; Ackerman, J. J.; Yablonskiy, D. A. Improved calibration technique for in vivo proton MRS thermometry for brain temperature measurement. Magn. Reson. Med. 2008, 60 (3), 536-41.
36. Lindner, U.; Ghai, S.; Spensieri, P.; Hlasny, E.; Van Der Kwast, T. H.; McCluskey, S. A.; Haider, M. A.; Kucharczyk, W.; Trachtenberg, J. Focal magnetic resonance guided focused ultrasound for prostate cancer: Initial North American experience. Can. Urol. Assoc. J. 2012, 6 (6), E283-6.
37. Hesley, G. K.; Gorny, K. R.; Woodrum, D. A. MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc. Interventional Radiol. 2013, 36 (1), 5-13.
38. McDannold, N.; Clement, G. T.; Black, P.; Jolesz, F.; Hynynen, K. Transcranial magnetic resonance imagingguided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery 2010, 66 (2), 323-32 discussion 332.
39. Clement, G. T.; Sun, J.; Giesecke, T.; Hynynen, K. A hemisphere array for non-invasive ultrasound brain therapy and surgery. Phys. Med. Biol. 2000, 45 (12), 3707-19.
40. Cohen, Z. R.; Zaubermann, J.; Harnof, S.; Mardor, Y.; Nass, D.; Zadicario, E.; Hananel, A.; Castel, D.; Faibel, M.; Ram, Z. Magnetic resonance imaging-guided focused ultrasound for thermal ablation in the brain: a feasibility study in a swine model. Neurosurgery 2007, 60 (4), 593-600 discussion 600.
41. Treat, L. H.; McDannold, N.; Zhang, Y.; Vykhodtseva, N.; Hynynen, K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med. Biol. 2012, 38 (10), 1716-25.
42. Wang, F.; Shi, Y.; Lu, L.; Liu, L.; Cai, Y.; Zheng, H.; Liu, X.; Yan, F.; Zou, C.; Sun, C.; Shi, J.; Lu, S.; Chen, Y. Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound. PLoS One 2012, 7 (12), e52925.
43. McDannold, N.; Moss, M.; Killiany, R.; Rosene, D. L.; King, R. L.; Jolesz, F. A.; Hynynen, K. MRI-guided focused ultrasound surgery in the brain: tests in a primate model. Magn. Reson. Med. 2003, 49 (6), 1188-91.
44. Khaibullina, A.; Jang, B. S.; Sun, H.; Le, N.; Yu, S.; Frenkel, V.; Carrasquillo, J. A.; Pastan, I.; Li, K. C.; Paik, C. H. Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J. Nucl. Med. 2008, 49 (2), 295-302.
45. Wu, C. Y.; Chan, P. C.; Chou, L. S.; Chang, C. W.; Yang, F. Y.; Liu, R. S.; Chiou, S. H.; Chen, Y. W.; Yen, S. H.; Wang, H. E. Pulsed-focused ultrasound enhances boron drug accumulation in a human head and neck cancer xenograft-bearing mouse model. Mol. Imaging Biol. 2014, 16 (1), 95-101.